Quick Takeaways
- RNLXY - Renalytix plc financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q3 2024.
- Headline metric: Return On Equity 438%.
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q3 2024.
Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.
See Original FilingLatest SEC snapshot (2024-09-30) highlights Return On Equity 437.6%, Return On Assets -230.4%, and Operating Margin -1054.9%.
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
36.7/100
Weak Confidence high
438%
Metric score 100.0/100
-230%
Metric score 0.0/100
Return On Equity and NetIncomeLoss YoY
Return On Assets, Operating Margin, and Current Ratio
Return On Equity
438%
YoY: -187%
Industry median: -5.8% (n=36)
Return On Assets
-230%
YoY: +53%
Industry median: -15% (n=35)
Operating Margin
-1055%
YoY: -23%
Industry median: -25% (n=27)
Current Ratio
0.24x
YoY: -78%
Industry median: 2.64x (n=36)
Quick Ratio
0.15x
YoY: -85%
Industry median: 2.05x (n=28)
Debt-to-equity
-1.86x
YoY: -168%
Industry median: 0.29x (n=33)
Revenues YoY
-19%
YoY:
Industry median: 12% (n=27)
NetIncomeLoss YoY
36%
YoY:
Industry median: -6.4% (n=32)
| Metric | Latest value | YoY change |
|---|---|---|
| Return On Equity | 438% | -187% |
| Return On Assets | -230% | +53% |
| Operating Margin | -1055% | -23% |
| Metric | Latest value | YoY change |
|---|---|---|
| Current Ratio | 0.24x | -78% |
| Quick Ratio | 0.15x | -85% |
| Debt-to-equity | -1.86x | -168% |
| Metric | Latest value | YoY change |
|---|---|---|
| Revenues YoY | -19% | |
| NetIncomeLoss YoY | 36% |
| Metric | Latest value | YoY change |
|---|---|---|
| Entity Common Stock, Shares Outstanding | 165,925,513 | +75% |
| Common Stock, Shares, Outstanding | 165,925,513 | +77% |
| Common Stock, Value, Issued | $515,000 | +78% |
| Weighted Average Number of Shares Outstanding, Basic | 105,697,401 | +12% |
| Weighted Average Number of Shares Outstanding, Diluted | 105,697,401 | +12% |
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
Metrics are computed with a market-consensus convention designed for cross-portal comparability.